Synthetic Biologics Inc Share Price Nyse
Equities
US87164U1025
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.11M 321M |
---|---|---|---|---|---|
Net income 2024 * | -28M -2.19B | Net income 2025 * | -34M -2.65B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.31
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.16% |
Latest transcript on Synthetic Biologics Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 31/05/15 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/12 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 31/12/05 |
John Monahan
BRD | Director/Board Member | 77 | 10/11/20 |
Jeffrey Kraws
CHM | Chairman | 59 | 31/12/05 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |